Laboratorios

Laboratorios Farmacéuticos Rovi (ROVI) is a leading Spanish pan-European pharmaceutical company specialized in the research, development, manufacturing, and marketing of small molecules and specialty medicines. The company is globally recognized for its proprietary ISM (In Situ Microparticles) technology platform, which enables the development of long-acting injectable formulations for chronic diseases such as schizophrenia. ROVI is also a major player in the low-molecular-weight heparin (LMWH) market and operates a significant contract development and manufacturing organization (CDMO) business, notably serving as a key manufacturing partner for Moderna's COVID-19 vaccine. Headquartered in Madrid, the company maintains a robust commercial presence across Europe and continues to expand its portfolio through internal R&D and strategic partnerships.